We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RENEW
1526
CALL
DELISTED
Cartesian Growth Corporation II Warrant
RENEW
$2.74M 0.01%
266,663
F icon
1527
CALL
Ford
F
$59.7B
$2.73M 0.01%
235,000
+154,100
+190% +$1.98M
GDEVW icon
1528
CALL
GDEV Inc Warrant
GDEVW
$60.8K
$2.73M 0.01%
427,197
ECXWW
1529
CALL
ECARX Holdings Warrants
ECXWW
$2.72M 0.01%
+340,100
New +$26.5K
PLUG icon
1530
Plug Power
PLUG
$2.82B
$2.71M 0.01%
219,300
-353,280
-62% -$5.62M
PSTX
1531
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$2.71M 0.01%
+511,404
New +$2.34M
NETI
1532
DELISTED
Eneti Inc.
NETI
$2.71M 0.01%
+269,628
New +$2.39M
TNL icon
1533
Travel + Leisure Co
TNL
$4.73B
$2.71M 0.01%
+74,400
New +$2.79M
WRAC.WS
1534
CALL
DELISTED
Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
WRAC.WS
$2.71M 0.01%
269,768
DE icon
1535
CALL
Deere & Co
DE
$172B
$2.7M 0.01%
+6,300
New +$2.56M
TXN icon
1536
PUT
Texas Instruments
TXN
$256B
$2.69M 0.01%
+16,300
New +$2.72M
UNH icon
1537
UnitedHealth
UNH
$386B
$2.69M 0.01%
5,071
-127,261
-96% -$67.4M
LSPD icon
1538
Lightspeed Commerce
LSPD
$1.4B
$2.69M 0.01%
+187,970
New +$3.06M
CCU icon
1539
Compañía de Cervecerías Unidas
CCU
$2.15B
$2.69M 0.01%
204,754
-358,367
-64% -$4.12M
ZEOWW
1540
CALL
Zeo Energy Corp Warrants
ZEOWW
$2.68M 0.01%
259,668
VLAT
1541
DELISTED
Valor Latitude Acquisition Corp. Class A Ordinary Shares
VLAT
$2.68M 0.01%
266,573
PICC.WS
1542
CALL
DELISTED
Pivotal Investment Corporation III Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
PICC.WS
$2.67M 0.01%
263,915
ONEM
1543
DELISTED
1Life Healthcare
ONEM
$2.67M 0.01%
159,798
+87,457
+121% +$1.48M
BZAI
1544
Blaize Holdings
BZAI
$121M
$2.67M 0.01%
262,705
IYG icon
1545
iShares US Financial Services ETF
IYG
$2.17B
$2.66M 0.01%
50,700
+18,600
+58% +$975K
PPL
1546
PPL Corp
PPL
$27.5B
$2.66M 0.01%
+90,976
New +$2.5M
SPHR icon
1547
Sphere Entertainment
SPHR
$4.93B
$2.66M 0.01%
+59,067
New +$2.68M
CSIQ icon
1548
Canadian Solar
CSIQ
$909M
$2.65M 0.01%
85,847
+75,647
+742% +$2.54M
DEA
1549
Easterly Government Properties
DEA
$1.18B
$2.65M 0.01%
+74,337
New +$2.89M
PSPC.WS
1550
CALL
DELISTED
Post Holdings Partnering Corporation Redeemable Warrants, each whole warrant exercisable for one share of Series A common stock at an exercise price of $11.50
PSPC.WS
$2.65M 0.01%
266,663

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.